Description
INFLUENZA VIRUS VACCINE - PRE-FILLED SINGLE DOSE SYRINGE (ADULT DOSE) (LATEX FREE, INCLUDING SYRINGE TIP CAP) (PRESERVATIVE FREE) (THIMEROSOL AND MERCURY FREE) NDC#: 33332-0013-01
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2013-06-24+$569,525= $569,525
- Mod P000012016-12-05+$169= $569,694
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2013-06-24 | +$569,525 | $569,525 | INFLUENZA VIRUS VACCINE - PRE-FILLED SINGLE DOSE SYRINGE (ADULT DOSE) (LATEX FREE, INCLUDING SYRINGE TIP CAP)… |
| Mod P00001· CHANGE ORDER | 2016-12-05 | +$169 | $569,694 | INFLUENZA VIRUS VACCINE - PRE-FILLED SINGLE DOSE SYRINGE (ADULT DOSE) (LATEX FREE, INCLUDING SYRINGE TIP CAP)… |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI N6U7P2B9VHS5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24626N0645 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6505 · DRUGS AND BIOLOGICALS | $167,990 | FY2026 |
| 36C26026N0271 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $69,996 | FY2026 |
| 36C24526N0409 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $125,993 | FY2026 |
| 36C24526N0395 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $151,658 | FY2026 |
| 36C24526N0422 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $130,659 | FY2026 |
| 36C24526N0427 | 245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS | $186,656 | FY2026 |
Other recipients under 6505 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0376 | RED RIVER PHARMACY OF JONESBORO, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $233,435 | FY2026 |
| 36C25526N0394 | NOVARTIS PHARMACEUTICALS CORPORATION | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $891,651 | FY2026 |
| 36C25526N0392 | SOFIE CO. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $357,066 | FY2026 |
| 36C25526N0361 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $228,679 | FY2026 |
| 36C25526D0057 | CARDINAL HEALTH 414, LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25513F3180_3600_VA797P13C0042_3600 · retrieved 2026-09-26.